themoneynarrative Viemed Healthcare (VMD.TO)/Protech Home Medical (PTQ.V) update

These companies have evolved considerably from the days of Patient Home Monitoring (previously PHM.V), which themoneynarrative readers will know if they have been following the story.  On November 13, 2017 we recommended that investors buy PHM.V under $0.30, telling readers that Continue reading “themoneynarrative Viemed Healthcare (VMD.TO)/Protech Home Medical (PTQ.V) update”